Clemson Rural Health, Guardian Research Network Partner to Improve Outcomes
Companies to collaborate on facilitating clinical trials in historically underserved regions.
Guardian Research Network (GRN) announced in a company press release that it has been joined by Clemson Rural Health to transform health outcomes in rural communities by conducting and facilitating clinical trials in historically underserved regions. GRN’s healthcare database is expected to help Clemson Rural Health bolster community health efforts to reduce premature mortality, decrease preventable hospitalizations and improve overall quality of life for local South Carolina patients.
"Partnering with Clemson Rural Health is a significant milestone for GRN," said Bruce Holstien, chairman, CEO, GRN. "Bringing this innovative team into our consortium demonstrates our unwavering commitment to improving access to cutting-edge studies in underserved communities. I look forward to the work we will accomplish together in our shared mission of driving community health advancements."
Reference: Clemson Rural Health Joins Forces with Guardian Research Network to Improve Community Health. PR Newswire. October 3, 2023. Accessed October 10, 2023. https://www.prnewswire.com/news-releases/clemson-rural-health-joins-forces-with-guardian-research-network-to-improve-community-health-301945161.html
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
